全文获取类型
收费全文 | 677347篇 |
免费 | 34412篇 |
国内免费 | 845篇 |
专业分类
耳鼻咽喉 | 8639篇 |
儿科学 | 21078篇 |
妇产科学 | 15917篇 |
基础医学 | 113484篇 |
口腔科学 | 17425篇 |
临床医学 | 57082篇 |
内科学 | 127815篇 |
皮肤病学 | 15834篇 |
神经病学 | 46405篇 |
特种医学 | 23233篇 |
外国民族医学 | 54篇 |
外科学 | 95246篇 |
综合类 | 8315篇 |
现状与发展 | 2篇 |
一般理论 | 132篇 |
预防医学 | 56611篇 |
眼科学 | 15935篇 |
药学 | 52925篇 |
2篇 | |
中国医学 | 1716篇 |
肿瘤学 | 34754篇 |
出版年
2021年 | 6282篇 |
2019年 | 6574篇 |
2018年 | 10341篇 |
2017年 | 7021篇 |
2016年 | 7746篇 |
2015年 | 8587篇 |
2014年 | 10680篇 |
2013年 | 15933篇 |
2012年 | 24947篇 |
2011年 | 27292篇 |
2010年 | 14878篇 |
2009年 | 12399篇 |
2008年 | 23827篇 |
2007年 | 26088篇 |
2006年 | 25251篇 |
2005年 | 24199篇 |
2004年 | 23127篇 |
2003年 | 22116篇 |
2002年 | 21274篇 |
2001年 | 26591篇 |
2000年 | 27515篇 |
1999年 | 22376篇 |
1998年 | 5885篇 |
1997年 | 4765篇 |
1996年 | 4817篇 |
1992年 | 16301篇 |
1991年 | 17533篇 |
1990年 | 17626篇 |
1989年 | 17022篇 |
1988年 | 15684篇 |
1987年 | 15460篇 |
1986年 | 14476篇 |
1985年 | 13933篇 |
1984年 | 10294篇 |
1983年 | 8764篇 |
1982年 | 4585篇 |
1979年 | 9941篇 |
1978年 | 7036篇 |
1977年 | 5807篇 |
1976年 | 6130篇 |
1975年 | 7337篇 |
1974年 | 8372篇 |
1973年 | 8124篇 |
1972年 | 7533篇 |
1971年 | 7202篇 |
1970年 | 6725篇 |
1969年 | 6348篇 |
1968年 | 6085篇 |
1967年 | 5442篇 |
1966年 | 4714篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
41.
42.
C. Dessinioti C.C. Zouboulis V. Bettoli D. Rigopoulos 《Journal of the European Academy of Dermatology and Venereology》2020,34(10):2229-2240
Guidelines and consensus on the management of patients with acne aim to give evidence-based, expert-group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice. 相似文献
43.
44.
45.
46.
Stelter K. Theodoraki M. N. Becker S. Tsekmistrenko V. Olzowy B. Ledderose G. 《European archives of oto-rhino-laryngology》2015,272(3):639-639
European Archives of Oto-Rhino-Laryngology - 相似文献
47.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献48.
49.
50.